Clinical Trials

Showing trials with last updates posted in 2026.

NCT05673408 | RECRUITING
189 participants

NIBP Validation Study

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-26
Start Date:
2023-06-23
Completion:
2027-03-31
Conditions
  • Critical Illness
Interventions
  • DEVICE
No Results Yet
NCT05642195 | SUSPENDED | PHASE1/PHASE2
30 participants

Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2026-05-28
Completion:
2033-12-30
Conditions
  • Non-Small Cell Lung Cancer
  • Non-Small Cell Lung Carcinoma
  • Carcinoma, Non-Small-Cell Lung
  • Carcinomas
Interventions
  • BIOLOGICAL
  • DRUG
  • DEVICE
No Results Yet
NCT05579366 | RECRUITING | PHASE1/PHASE2
884 participants

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2022-12-07
Completion:
2027-07-31
Conditions
  • High Grade Epithelial Ovarian Cancer
  • High Grade Serous Ovarian Cancer
  • Primary Peritoneal Carcinoma
  • Fallopian Tube Cancer
  • Endometrial Cancer
  • Non-small Cell Lung Cancer
  • Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC)
  • Mesothelioma
  • Breast Adenocarcinoma
  • Triple Negative Breast Cancer
  • Hormone Receptor-positive/Her2 Negative Breast Cancer
  • Platinum-resistant Ovarian Cancer (PROC)
  • Platinum Sensitive Ovarian Cancer (PSOC)
  • Primary Refractory Ovarian Cancer
  • Uterine Cancer
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page